Search research articles
Contact Us
Filters
Showing results (1-10 of 263) with videos related to
Page
of 27
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 21, 2025
Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?
Sreeram V Ramagopalan
Lancet (London, England)
|
June 28, 2025
Population health impact of NICE-recommended new drugs
Sreeram V Ramagopalan
New Biotechnology
|
May 28, 2008
Life on top-working@ the Wellcome Trust Centre for Human Genetics: Scotland Yard for DNA detectives
Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
May 6, 2021
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment
Alex Simpson, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
March 9, 2022
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6
Alex Simpson, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
June 29, 2021
R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2
Alex Simpson, Sreeram V Ramagopalan
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 28, 2012
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Giulio Disanto, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
June 22, 2023
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12
Ben Bray, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
February 18, 2025
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18
Paul Arora, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
October 2, 2025
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 21
Paul Arora, Sreeram V Ramagopalan
Page
of 27
Search research articles
Search
Showing results (1-10 of 263) with videos related to
Sort By:
Page
of 27
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 21, 2025
Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?
Sreeram V Ramagopalan
Lancet (London, England)
|
June 28, 2025
Population health impact of NICE-recommended new drugs
Sreeram V Ramagopalan
New Biotechnology
|
May 28, 2008
Life on top-working@ the Wellcome Trust Centre for Human Genetics: Scotland Yard for DNA detectives
Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
May 6, 2021
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment
Alex Simpson, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
March 9, 2022
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6
Alex Simpson, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
June 29, 2021
R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2
Alex Simpson, Sreeram V Ramagopalan
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 28, 2012
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Giulio Disanto, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
June 22, 2023
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12
Ben Bray, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
February 18, 2025
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18
Paul Arora, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
|
October 2, 2025
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 21
Paul Arora, Sreeram V Ramagopalan
Page
of 27